News
Breast Cancer New Drug: OBI-822/821 received Taiwan FDA Approval for entering Phase III trial
Breast Cancer New Drug:OBI-822/821 received Taiwan FDA Approval for entering …
2012-08-08
DIFICID (Fidaxomicin) Approved by Taiwan Department of Health for the Treatment of CDAD
DIFICID® (Fidaxomicin) Approved by Taiwan Department of Health for the …
2012-07-20